Jay Lichter

Insider Reports History

Entity
Individual
Location
C/O Aratana Therapeutics, Inc., 11400 Tomahawk Creek Parkway, Suite 340, Leawood, KS
Signature
/s/ Jay B. Lichter
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jay Lichter:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. 10%+ Owner Common Stock 3.02M $135M $44.75 Sep 13, 2024 By Avalon BioVentures SPV I, L.P.
Janux Therapeutics, Inc. 10%+ Owner Common Stock 2.96M $132M $44.75 Sep 13, 2024 By Avalon Ventures XI, L.P.
Janux Therapeutics, Inc. 10%+ Owner Common Stock 573K $25.7M $44.75 Sep 13, 2024 By Avalon BioVentures I, LP
Janux Therapeutics, Inc. 10%+ Owner Common Stock 7K $327K $46.68 Sep 13, 2024 Direct
OTONOMY, INC. Director Stock Option (right to buy) 27.5K Jun 21, 2022 Direct
Janux Therapeutics, Inc. 10%+ Owner Stock Option (right to buy) 7.68K Sep 13, 2024 Direct

Insider Reports Filed by Jay Lichter

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Sep 13, 2024 9 -$112K 4 Oct 24, 2024 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 26, 2024 2 $0 4 Jun 28, 2024 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 3, 2024 3 -$82.1M 4 Jun 5, 2024 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Nov 13, 2023 1 $4.99M 4 Nov 15, 2023 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director, 10%+ Owner
OTIC OTONOMY, INC. Jun 21, 2022 1 $0 4 Jun 23, 2022 Director
JANX Janux Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director, 10%+ Owner
OTIC OTONOMY, INC. Jun 22, 2021 1 $0 4 Jun 24, 2021 Director
JANX Janux Therapeutics, Inc. Jun 15, 2021 11 $10.7M 4 Jun 16, 2021 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director, 10%+ Owner
JANX Janux Therapeutics, Inc. Jun 10, 2021 0 $0 3 Jun 10, 2021 Director, 10%+ Owner